Careers  |  Sign In  |  Register

Latest in Nurses/NP/PA

Reuters Health • The Doctor's Channel Daily Newscast

Investigational sumatriptan patch shows efficacy, tolerability over 12 months

NEW YORK (Reuters Health) – A transdermal sumatriptan formulation, NP101, in development for acute treatment of migraine, remains effective during a year of successive uses, according to a report in Headache online February 21. “Because its use does not entail oral or intranasal administration and...

Reuters Health • The Doctor's Channel Daily Newscast

Renin-angiotensin blockade helpful in heart failure with renal disease

NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study suggests. The study found that being prescribed an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor...

Reuters Health • The Doctor's Channel Daily Newscast

Reassuring data on cancer risk with omalizumab therapy

NEW YORK (Reuters Health) - A new analysis of pooled data on omalizumab should help allay concerns that omalizumab (Xolair; Genentech, Novartis) may increase the risk for cancer. The analysis of 67 clinical trials found no association between omalizumab treatment and risk of malignancy. A causal...